| NephRx Corp. Initiates Phase I Trial of its Lead Drug Being Developed for ... - PR Newswire (press release) |
|
| PR Newswire (press release)NX001, a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure, |